2023
DOI: 10.1158/1078-0432.c.6518991.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Data from Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity

Abstract: <div>Abstract<p><b>Purpose:</b> Phosphorylated histone H2AX (γH2AX) serves as a biomarker for formation of DNA double-strand break repair complexes. A quantitative pharmacodynamic immunofluorescence assay for γH2AX was developed, validated, and tested in human tumor xenograft models with the use of clinically relevant procedures.</p><p><b>Experimental Design:</b> The γH2AX immunofluorescence assay uses a novel data quantitation and image processing algorithm to d… Show more

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles